Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin
Background. Hearing is essential in child development. Cisplatin which is a common chemotherapy used in many pediatric solid-tumor protocols cause various degrees of ototoxicity. Several risk factors for cisplatininduced ototoxicity have been reported, including race and age. This study aimed...
Saved in:
| Main Authors: | Tatpong Sriyapai, Kanthong Thongyai, Kamon Phuakpet, Nassawee Vathana, Jassada Buaboonnam, Kleebsabai Sanpakit |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2022-06-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/179 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Strategies to Mitigate Cisplatin-Induced Ototoxicity: A Literature Review of Protective Agents, Mechanisms, and Clinical Gaps
by: Alexandru Orasan, et al.
Published: (2025-02-01) -
New application of ombuoside in protecting auditory cells from cisplatin-induced ototoxicity via the apoptosis pathway
by: Xingxing Wu, et al.
Published: (2024-10-01) -
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
by: Nesrine Benkafadar, et al.
Published: (2016-10-01) -
Sarsasapogenin protects hair cells from cisplatin-induced ototoxicity by attenuating apoptosis and ferroptosis via alleviating oxidative stress
by: Zhifeng Chen, et al.
Published: (2025-08-01) -
Ferulic Acid Combines with Ascorbic Acid to Target MMP9 to Attenuate Cisplatin-Induced Ototoxicity Through the p38MAPK Signaling Pathway
by: Guojun Yang, et al.
Published: (2025-05-01)